Article Text

other Versions

PDF
Original article
miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer
  1. Yanlei Ma1,
  2. Peng Zhang1,
  3. Feng Wang1,
  4. Huizhen Zhang2,
  5. Jianjun Yang1,
  6. Jiayuan Peng1,
  7. Weijie Liu1,
  8. Huanlong Qin1
  1. 1Department of General Surgery, The Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, P R China
  2. 2Department of Pathology, The Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, P R China
  1. Correspondence to Dr Huanlong Qin, Department of Surgery, The Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, P R China; hl-qin{at}hotmail.com
  2. Yanlei Ma Department of General Surgery, The Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China; yanleima{at}live.cn

Abstract

Background MicroRNAs (miRNA) have potential as prognostic biomarkers and therapeutic targets in cancer. A study was undertaken to investigate the association between miRNA expression patterns and the prognosis and therapeutic outcome of colorectal cancer (CRC).

Methods miRNA expression profiling in tumour, adenoma and normal colorectal tissues was performed to identify tumour-related miRNAs in the course of colorectal malignant changes. Quantitative reverse transcription PCR (qRT-PCR) assays were used to measure tumour-related miRNA and to assess its association with survival and response to adjuvant chemotherapy in 239 patients. In addition, to validate the findings, associations of the tumour-related miRNA with clinical characteristics of CRC were analysed in 185 patients by in situ hybridisation (ISH) analysis.

Results Only one miR-150 was found to show a decrease in expression levels in the three tissue groups (normal, adenoma and cancer tissue) in parallel with increasing carcinogenesis of the colorectal tissue. In both ISH and qRT-PCR analysis, tumour tissue had reduced levels of miR-150 expression compared with paired non-cancerous tissue, which indicated that the levels of miR-150 expression were associated with CRC. Moreover, patients whose tumours had low miR-150 expression had shorter survival and a worse response to adjuvant chemotherapy than patients whose tumours had high miRNA expression.

Conclusions The miR-150 expression status of patients with CRC is associated with survival and response to adjuvant chemotherapy. It is suggested that miR-150 should be considered as a potential biomarker associated with the prognosis and therapeutic outcome in CRC.

  • miR-150
  • colorectal cancer
  • prognosis
  • therapy
  • cancer

Statistics from Altmetric.com

Footnotes

  • YM and HQ contributed equally to this work and are co-corresponding authors.

  • The full trial protocol can be accessed from Dr HQ and via email tohl-qin{at}hotmail.com

  • Funding This work was financially sponsored by Shanghai Rising-Star Program (No. 11QA1404800), grants from the National Natural Science Foundation of China (No. 81001069) and the National 863 High Technology Foundation (No. 2009AA02Z118).

  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval The institutional review board of the Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, China.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Digest
    Emad El-Omar William Grady Alexander Gerbes